Holen Sie sich die Stockscreener-App
58.05
3.68%
2.06
Handel nachbörslich:
57.80
-0.25
-0.43%
Hinge Health Inc Aktie (HNGE) Neueste Nachrichten
Hinge Health Announces Early Share Lock-Up Release - TipRanks
Digital health Q2 earnings: New guys win, GLP-1 companies lose - Modern Healthcare
Baron Small Cap Fund is Excited to Invest in Hinge Health (HNGE). Here’s Why - Insider Monkey
Is hnge a buy sell or hold - AInvest
Hinge Health (NYSE:HNGE) Shares Down 7.1%Should You Sell? - MarketBeat
Hinge Health (NYSE:HNGE) Price Target Raised to $65.00 - MarketBeat
Hinge Health (NYSE:HNGE) Reaches New 12-Month High Following Analyst Upgrade - MarketBeat
Hinge Health (NYSE:HNGE) Stock Price Expected to Rise, Canaccord Genuity Group Analyst Says - MarketBeat
Hinge Health (NYSE:HNGE) Given New $60.00 Price Target at Evercore ISI - MarketBeat
Morgan Stanley Raises Hinge Health (NYSE:HNGE) Price Target to $57.00 - MarketBeat
Bank of America Forecasts Strong Price Appreciation for Hinge Health (NYSE:HNGE) Stock - MarketBeat
Hinge Health, Inc. Class A Common Stock (NYSE:HNGE) Stock Quote - FinancialContent
Hinge Health shares fall 1.26% intraday as Trump's import taxes raise economic concerns. - AInvest
Brokerages Set Hinge Health Inc. (NYSE:HNGE) Price Target at $49.86 - Defense World
Hinge Health Inc. (NYSE:HNGE) Given Average Rating of "Buy" by Analysts - MarketBeat
Morgan Stanley Forecasts Strong Price Appreciation for Hinge Health (NYSE:HNGE) Stock - Defense World
Barclays Boosts Hinge Health (NYSE:HNGE) Price Target to $62.00 - MarketBeat
Needham & Company LLC Forecasts Strong Price Appreciation for Hinge Health (NYSE:HNGE) Stock - MarketBeat
Hinge Health price target raised to $62 from $48 at Truist - Yahoo Finance
Hinge Health’s Strategic Growth and Market Positioning: A Buy Recommendation by Ryan MacDonald - TipRanks
Hinge Health (NYSE:HNGE) Sets New 52-Week High on Analyst Upgrade - Defense World
Hinge Health: Is It Too Late to Buy? - timothysykes.com
Hinge Health’s Strong Growth and Margin Improvements Drive Buy Rating and Increased Price Objective - TipRanks
Hinge Health shares rise 23.34% intraday after RBC raised its price target to $60. - AInvest
TR | OpenAI4o Initiates Hinge Health(HNGE.US) With Hold Rating, Announces Target Price $52 - 富途牛牛
Hinge Health's Q2 Earnings Surge: A Case Study in Long-Term Value Creation Post-IPO - AInvest
Hinge Health's Q2 Earnings: A Strategic Bet on AI-Driven Healthcare Automation - AInvest
Hinge Health Q2 beat: 'Long-term' thinking is key, CEO says - Yahoo Finance
Hinge Health's AI-Driven Surge: Redefining Digital Healthcare Profitability Post-IPO - AInvest
Hinge Health beats Wall Street expectations on revenue in first public earnings - Healthcare Dive
Hinge Health price target raised to $63 from $55 at Stifel - TipRanks
Hinge Health Climbs Amidst Strategic Acquisitions and Expanding Horizons - StocksToTrade
Hinge Health price target raised to $59 from $47 at Needham - TipRanks
Elevating Dynamics: Hinge Health’s Strategic Moves Stir Market Pattens - timothysykes.com
Hinge Health's Post-IPO Surge: Clinical Excellence and Employer Adoption Fuel a New Era in Digital MSK Care - AInvest
Hinge Health Gains in Market Debut, Providing a Favorable Sign for IPOs -- Update - 富途牛牛
Hinge Health Soars 22.7% on Q2 Earnings Surge: Can This AI-Powered Healthcare Play Sustain Momentum? - AInvest
Why are Hinge Health’s Shares Surging in Premarket Trading Today? - Tokenist
RBC Raises Price Target on Hinge Health to $60 From $45, Keeps Outperform Rating - MarketScreener
Hinge Health's Post-IPO Surge: A Test of Fundamentals in the Digital Therapeutics Gold Rush - AInvest
Hinge Health price target raised to $57 from $46 at Morgan Stanley - TipRanks
Stifel raises Hinge Health stock price target to $63 on strong Q2 results - Investing.com Nigeria
Hinge Health shares rise 7.84% premarket after Q2 2025 earnings call and revenue growth. - AInvest
Citizens JMP raises Hinge Health stock price target to $65 on strong earnings - Investing.com Australia
Hinge Health Reports Strong Q2 2025 Growth - TipRanks
Hinge Health's Q2 2025 Earnings: A Blueprint for Scalable AI-Driven Healthcare Growth - AInvest
Hinge Health Q2 Earnings: Revenue Beats Expectations, EPS Misses - AInvest
Hinge Health, Inc. shares rise 5.13% after-hours following Q3 revenue range expectations. - AInvest
Hinge Health's 52% Revenue Surge: How AI-Powered Care is Reshaping Digital Health Economics - AInvest
Hinge Health Reports Strong Q2 2025 Revenue Growth - TipRanks
Hinge Health's Q3 Revenue Exceeds Expectations, Shares Surge 10% - AInvest
Hinge Health stock pops 6% after first quarterly report since IPO - CNBC
(HNGE) Hinge Health, Inc. Expects Q3 Revenue Range $141.0M$143.0M - MarketScreener
Hinge Health reports Q2 EPS ($13.10) vs (96c) last year - TipRanks
Hinge Health Reports Second Quarter 2025 Financial Results - Business Wire
Stifel Nicolaus Forecasts Strong Price Appreciation for Hinge Health (NYSE:HNGE) Stock - Defense World
6.58%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):